Henry Schein, Inc. (HSIC)

$72.16

+1.12

(+1.58%)▲

Live

Performance

  • $71.34
    $72.36
    $72.16
    downward going graph

    1.14%

    Downside

    Day's Volatility :1.41%

    Upside

    0.28%

    downward going graph
  • $60.01
    $82.63
    $72.16
    downward going graph

    16.84%

    Downside

    52 Weeks Volatility :27.38%

    Upside

    12.67%

    downward going graph

Returns

PeriodHenry Schein, Inc.Sector (Health Care)S&P500
3 Months
-2.86%
6.5%
5.9%
6 Months
-4.26%
7.1%
10.4%
1 Year
-11.0%
9.8%
18.2%
3 Years
-8.18%
14.2%
22.1%

Highlights

Market Capitalization
9.0B
Book Value
$28.02
Earnings Per Share (EPS)
2.97
PE Ratio
23.67
PEG Ratio
1.65
Wall Street Target Price
78.5
Profit Margin
3.12%
Operating Margin TTM
5.74%
Return On Assets TTM
4.44%
Return On Equity TTM
8.34%
Revenue TTM
12.5B
Revenue Per Share TTM
95.81
Quarterly Revenue Growth YOY
3.6999999999999997%
Gross Profit TTM
3.8B
EBITDA
934.0M
Diluted Eps TTM
2.97
Quarterly Earnings Growth YOY
-0.56
EPS Estimate Current Year
5.07
EPS Estimate Next Year
5.58
EPS Estimate Current Quarter
1.01
EPS Estimate Next Quarter
1.27

Analyst Recommendation

Hold
    42%Buy
    47%Hold
    9%Sell
Based on 21 Wall street analysts offering stock ratings for Henry Schein, Inc.(by analysts ranked 0 to 5 stars)
Based on 21 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
9
9
Hold
10
10
9
Sell
2
2
2

Analyst Forecast

What analysts predicted

Upside of 8.79%

Current $72.16
Target $78.50

Company Financials

FY18Y/Y Change
Revenue
13.2B
↑ 5.94%
Net Income
535.9M
↑ 31.89%
Net Profit Margin
4.06%
↑ 0.8%
FY19Y/Y Change
Revenue
10.0B
↓ 24.36%
Net Income
520.8M
↓ 2.82%
Net Profit Margin
5.22%
↑ 1.16%
FY20Y/Y Change
Revenue
10.1B
↑ 1.34%
Net Income
403.8M
↓ 22.47%
Net Profit Margin
3.99%
↓ 1.23%
FY21Y/Y Change
Revenue
12.4B
↑ 22.55%
Net Income
631.0M
↑ 56.27%
Net Profit Margin
5.09%
↑ 1.1%
FY22Y/Y Change
Revenue
12.6B
↑ 1.98%
Net Income
538.0M
↓ 14.74%
Net Profit Margin
4.25%
↓ 0.84%
FY23Y/Y Change
Revenue
12.3B
↓ 2.44%
Net Income
416.0M
↓ 22.68%
Net Profit Margin
3.37%
↓ 0.88%
Q4 FY22Q/Q Change
Revenue
3.4B
↑ 9.91%
Net Income
47.0M
↓ 68.67%
Net Profit Margin
1.39%
↓ 3.5%
Q1 FY23Q/Q Change
Revenue
3.1B
↓ 9.23%
Net Income
121.0M
↑ 157.45%
Net Profit Margin
3.95%
↑ 2.56%
Q2 FY23Q/Q Change
Revenue
3.1B
↑ 1.31%
Net Income
140.0M
↑ 15.7%
Net Profit Margin
4.52%
↑ 0.57%
Q3 FY23Q/Q Change
Revenue
3.2B
↑ 2.0%
Net Income
137.0M
↓ 2.14%
Net Profit Margin
4.33%
↓ 0.19%
Q4 FY23Q/Q Change
Revenue
3.0B
↓ 4.59%
Net Income
18.0M
↓ 86.86%
Net Profit Margin
0.6%
↓ 3.73%
Q1 FY24Q/Q Change
Revenue
3.2B
↑ 5.14%
Net Income
93.0M
↑ 416.67%
Net Profit Margin
2.93%
↑ 2.33%
FY18Y/Y Change
Total Assets
8.5B
↑ 8.82%
Total Liabilities
5.0B
↑ 19.35%
FY19Y/Y Change
Total Assets
7.2B
↓ 15.87%
Total Liabilities
3.5B
↓ 28.99%
FY20Y/Y Change
Total Assets
7.8B
↑ 8.69%
Total Liabilities
3.8B
↑ 7.59%
FY21Y/Y Change
Total Assets
8.5B
↑ 9.12%
Total Liabilities
4.4B
↑ 16.62%
FY22Y/Y Change
Total Assets
8.6B
↑ 1.48%
Total Liabilities
3.9B
↓ 10.91%
FY23Y/Y Change
Total Assets
10.6B
↑ 22.84%
Total Liabilities
5.4B
↑ 37.7%
Q4 FY22Q/Q Change
Total Assets
8.6B
↑ 0.86%
Total Liabilities
3.9B
↑ 5.64%
Q1 FY23Q/Q Change
Total Assets
8.6B
↓ 0.41%
Total Liabilities
3.9B
↓ 1.55%
Q2 FY23Q/Q Change
Total Assets
9.1B
↑ 6.7%
Total Liabilities
4.1B
↑ 6.84%
Q3 FY23Q/Q Change
Total Assets
9.8B
↑ 7.26%
Total Liabilities
4.7B
↑ 13.74%
Q4 FY23Q/Q Change
Total Assets
10.6B
↑ 7.78%
Total Liabilities
5.4B
↑ 15.1%
Q1 FY24Q/Q Change
Total Assets
10.1B
↓ 4.05%
Total Liabilities
5.1B
↓ 5.72%
FY18Y/Y Change
Operating Cash Flow
684.7M
↑ 25.52%
Investing Cash Flow
-193.0M
↓ 43.63%
Financing Cash Flow
-603.8M
↑ 436.45%
FY19Y/Y Change
Operating Cash Flow
654.1M
↓ 4.47%
Investing Cash Flow
-424.4M
↑ 119.93%
Financing Cash Flow
-216.0M
↓ 64.23%
FY20Y/Y Change
Operating Cash Flow
598.9M
↓ 8.44%
Investing Cash Flow
-115.0M
↓ 72.9%
Financing Cash Flow
-187.2M
↓ 13.33%
FY21Y/Y Change
Operating Cash Flow
709.6M
↑ 18.48%
Investing Cash Flow
-677.2M
↑ 488.79%
Financing Cash Flow
-333.0M
↑ 77.88%
FY22Y/Y Change
Operating Cash Flow
602.0M
↓ 15.16%
Investing Cash Flow
-276.0M
↓ 59.24%
Financing Cash Flow
-315.0M
↓ 5.39%
Q4 FY22Q/Q Change
Operating Cash Flow
254.0M
↑ 159.18%
Investing Cash Flow
-65.0M
↓ 57.24%
Financing Cash Flow
-194.0M
↓ 362.16%
Q1 FY23Q/Q Change
Operating Cash Flow
27.0M
↓ 89.37%
Investing Cash Flow
-39.0M
↓ 40.0%
Financing Cash Flow
21.0M
↓ 110.82%
Q2 FY23Q/Q Change
Operating Cash Flow
274.0M
↑ 914.81%
Investing Cash Flow
-301.0M
↑ 671.79%
Financing Cash Flow
38.0M
↑ 80.95%

Technicals Summary

Sell

Neutral

Buy

Henry Schein, Inc. is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Henry Schein, Inc.
Henry Schein, Inc.
10.04%
-4.26%
-11.0%
-8.18%
4.78%
Cardinal Health, Inc.
Cardinal Health, Inc.
-4.14%
-8.32%
5.02%
64.31%
114.78%
Cencora Inc
Cencora Inc
-4.29%
4.33%
26.95%
64.85%
115.93%
Mckesson Corporation
Mckesson Corporation
-0.64%
22.76%
47.53%
194.19%
328.74%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Henry Schein, Inc.
Henry Schein, Inc.
23.67
23.67
1.65
5.07
0.08
0.04
NA
28.02
Cardinal Health, Inc.
Cardinal Health, Inc.
42.79
42.79
0.31
7.36
0.0
0.03
0.02
-13.38
Cencora Inc
Cencora Inc
24.88
24.88
1.58
13.47
2.13
0.03
0.01
5.43
Mckesson Corporation
Mckesson Corporation
26.39
26.39
4.96
27.59
0.0
0.04
0.0
-15.16
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Henry Schein, Inc.
Henry Schein, Inc.
Hold
$9.0B
4.78%
23.67
3.12%
Cardinal Health, Inc.
Cardinal Health, Inc.
Hold
$23.6B
114.78%
42.79
0.25%
Cencora Inc
Cencora Inc
Buy
$44.7B
115.93%
24.88
0.67%
Mckesson Corporation
Mckesson Corporation
Buy
$76.5B
328.74%
26.39
0.97%

Insights on Henry Schein, Inc.

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 3.01B → 3.17B (in $), with an average increase of 4.9% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, 18.0M → 93.0M (in $), with an average increase of 80.7% per quarter

  • Vs MCK

    In the last 1 year, Mckesson Corporation has given 47.5% return, outperforming this stock by 58.5%

  • Vs MCK

    In the last 3 years, Mckesson Corporation has given 194.2% return, outperforming this stock by 202.4%

Institutional Holdings

  • Vanguard Group Inc

    12.05%

  • Generation Investment Management LLP

    7.91%

  • BlackRock Inc

    7.65%

  • State Street Corporation

    4.99%

  • Amvescap Plc.

    4.89%

  • Artisan Partners Limited Partnership

    4.74%

Company Information

henry schein, inc. is the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners. the company also serves dental laboratories, government and institutional health care clinics, and other alternate care sites. a fortune 500® company and a member of the s&p 500® and nasdaq 100® indexes, henry schein employs more than 18,000 team schein members and serves more than one million customers. the company offers a comprehensive selection of products and services, including value-added solutions for operating efficient practices and delivering high-quality care. henry schein operates through a centralized and automated distribution network, with a selection of more than 100,000 branded products and henry schein private-brand products in stock, as well as more than 150,000 additional products available as special-order items. the company also offers its customers exclusive, innovative technology solutions, including practice

Organization
Henry Schein, Inc.
Employees
25000
CEO
Mr. Stanley M. Bergman
Industry
Wholesale Trade

Discover More

FAQs